HEADER CYTOKINE 17-APR-00 1EUJ TITLE A NOVEL ANTI-TUMOR CYTOKINE CONTAINS A RNA-BINDING MOTIF PRESENT IN TITLE 2 AMINOACYL-TRNA SYNTHETASES COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: EMAP 2; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS EMAP 2, EMAP II, CYTOKINE, TRNA SYNTHETASE, APOPTOSIS, RNA BINDING KEYWDS 2 MOTIF EXPDTA X-RAY DIFFRACTION AUTHOR Y.KIM,J.SHIN,R.LI,C.CHEONG,S.KIM REVDAT 5 07-FEB-24 1EUJ 1 REMARK REVDAT 4 31-JAN-18 1EUJ 1 REMARK REVDAT 3 24-FEB-09 1EUJ 1 VERSN REVDAT 2 01-APR-03 1EUJ 1 JRNL REVDAT 1 06-SEP-00 1EUJ 0 JRNL AUTH Y.KIM,J.SHIN,R.LI,C.CHEONG,K.KIM,S.KIM JRNL TITL A NOVEL ANTI-TUMOR CYTOKINE CONTAINS AN RNA BINDING MOTIF JRNL TITL 2 PRESENT IN AMINOACYL-TRNA SYNTHETASES. JRNL REF J.BIOL.CHEM. V. 275 27062 2000 JRNL REFN ISSN 0021-9258 JRNL PMID 10852899 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 30829 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2329 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2508 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 193 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.580 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1EUJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-APR-00. REMARK 100 THE DEPOSITION ID IS D_1000010903. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-NOV-98 REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31502 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.800 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.2 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 31.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.89 REMARK 200 COMPLETENESS FOR SHELL (%) : 37.9 REMARK 200 DATA REDUNDANCY IN SHELL : 1.40 REMARK 200 R MERGE FOR SHELL (I) : 0.28200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 4000, 100 MM NAACETATE, 15 MM REMARK 280 MGCL2, PH 4.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 21K, REMARK 280 TEMPERATURE 294.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 67.00500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.17000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 67.00500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.17000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER IN VIVO, BUT FORMS A REMARK 300 DIMER IN A ASYMMETRIC UNIT IN CRYSTAL BY THE TWO-FOLD. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 LYS A 2 REMARK 465 SER B 1 REMARK 465 LYS B 2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PRO A 3 CG CD REMARK 470 PRO B 3 CG CD REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 25 101.26 -170.90 REMARK 500 HIS A 50 -32.78 -135.64 REMARK 500 REMARK 500 REMARK: NULL DBREF 1EUJ A 1 166 UNP Q12904 MCA1_HUMAN 145 310 DBREF 1EUJ B 1 166 UNP Q12904 MCA1_HUMAN 145 310 SEQRES 1 A 166 SER LYS PRO ILE ASP VAL SER ARG LEU ASP LEU ARG ILE SEQRES 2 A 166 GLY CYS ILE ILE THR ALA ARG LYS HIS PRO ASP ALA ASP SEQRES 3 A 166 SER LEU TYR VAL GLU GLU VAL ASP VAL GLY GLU ILE ALA SEQRES 4 A 166 PRO ARG THR VAL VAL SER GLY LEU VAL ASN HIS VAL PRO SEQRES 5 A 166 LEU GLU GLN MET GLN ASN ARG MET VAL ILE LEU LEU CYS SEQRES 6 A 166 ASN LEU LYS PRO ALA LYS MET ARG GLY VAL LEU SER GLN SEQRES 7 A 166 ALA MET VAL MET CYS ALA SER SER PRO GLU LYS ILE GLU SEQRES 8 A 166 ILE LEU ALA PRO PRO ASN GLY SER VAL PRO GLY ASP ARG SEQRES 9 A 166 ILE THR PHE ASP ALA PHE PRO GLY GLU PRO ASP LYS GLU SEQRES 10 A 166 LEU ASN PRO LYS LYS LYS ILE TRP GLU GLN ILE GLN PRO SEQRES 11 A 166 ASP LEU HIS THR ASN ASP GLU CYS VAL ALA THR TYR LYS SEQRES 12 A 166 GLY VAL PRO PHE GLU VAL LYS GLY LYS GLY VAL CYS ARG SEQRES 13 A 166 ALA GLN THR MET SER ASN SER GLY ILE LYS SEQRES 1 B 166 SER LYS PRO ILE ASP VAL SER ARG LEU ASP LEU ARG ILE SEQRES 2 B 166 GLY CYS ILE ILE THR ALA ARG LYS HIS PRO ASP ALA ASP SEQRES 3 B 166 SER LEU TYR VAL GLU GLU VAL ASP VAL GLY GLU ILE ALA SEQRES 4 B 166 PRO ARG THR VAL VAL SER GLY LEU VAL ASN HIS VAL PRO SEQRES 5 B 166 LEU GLU GLN MET GLN ASN ARG MET VAL ILE LEU LEU CYS SEQRES 6 B 166 ASN LEU LYS PRO ALA LYS MET ARG GLY VAL LEU SER GLN SEQRES 7 B 166 ALA MET VAL MET CYS ALA SER SER PRO GLU LYS ILE GLU SEQRES 8 B 166 ILE LEU ALA PRO PRO ASN GLY SER VAL PRO GLY ASP ARG SEQRES 9 B 166 ILE THR PHE ASP ALA PHE PRO GLY GLU PRO ASP LYS GLU SEQRES 10 B 166 LEU ASN PRO LYS LYS LYS ILE TRP GLU GLN ILE GLN PRO SEQRES 11 B 166 ASP LEU HIS THR ASN ASP GLU CYS VAL ALA THR TYR LYS SEQRES 12 B 166 GLY VAL PRO PHE GLU VAL LYS GLY LYS GLY VAL CYS ARG SEQRES 13 B 166 ALA GLN THR MET SER ASN SER GLY ILE LYS FORMUL 3 HOH *193(H2 O) HELIX 1 1 ASP A 5 LEU A 9 5 5 HELIX 2 2 PRO A 52 MET A 56 5 5 HELIX 3 3 ASN A 119 LYS A 122 5 4 HELIX 4 4 LYS A 123 GLN A 129 1 7 HELIX 5 5 ASP B 5 LEU B 9 5 5 HELIX 6 6 PRO B 52 MET B 56 5 5 HELIX 7 7 ASN B 119 LYS B 122 5 4 HELIX 8 8 LYS B 123 GLN B 129 1 7 SHEET 1 A 5 ARG A 41 SER A 45 0 SHEET 2 A 5 ALA A 25 ASP A 34 -1 N TYR A 29 O SER A 45 SHEET 3 A 5 LEU A 11 HIS A 22 -1 O CYS A 15 N ASP A 34 SHEET 4 A 5 MET A 60 LEU A 64 -1 N VAL A 61 O GLY A 14 SHEET 5 A 5 MET A 80 VAL A 81 -1 O MET A 80 N LEU A 64 SHEET 1 B 2 ALA A 70 MET A 72 0 SHEET 2 B 2 VAL A 75 SER A 77 -1 O VAL A 75 N MET A 72 SHEET 1 C 2 CYS A 83 SER A 85 0 SHEET 2 C 2 ILE A 90 ILE A 92 -1 O GLU A 91 N ALA A 84 SHEET 1 D 3 LEU A 132 THR A 134 0 SHEET 2 D 3 ALA A 140 TYR A 142 -1 O THR A 141 N HIS A 133 SHEET 3 D 3 VAL A 145 PRO A 146 -1 N VAL A 145 O TYR A 142 SHEET 1 E 2 GLU A 148 VAL A 149 0 SHEET 2 E 2 GLY A 153 VAL A 154 -1 O GLY A 153 N VAL A 149 SHEET 1 F 5 ARG B 41 SER B 45 0 SHEET 2 F 5 TYR B 29 ASP B 34 -1 N TYR B 29 O SER B 45 SHEET 3 F 5 LEU B 11 LYS B 21 -1 O CYS B 15 N ASP B 34 SHEET 4 F 5 ARG B 59 LEU B 64 -1 O ARG B 59 N ILE B 16 SHEET 5 F 5 MET B 80 VAL B 81 -1 O MET B 80 N LEU B 64 SHEET 1 G 2 ALA B 70 LYS B 71 0 SHEET 2 G 2 LEU B 76 SER B 77 -1 N SER B 77 O ALA B 70 SHEET 1 H 3 ILE B 90 ILE B 92 0 SHEET 2 H 3 CYS B 83 SER B 85 -1 N ALA B 84 O GLU B 91 SHEET 3 H 3 GLY B 164 ILE B 165 -1 O GLY B 164 N SER B 85 SHEET 1 I 3 LEU B 132 THR B 134 0 SHEET 2 I 3 ALA B 140 TYR B 142 -1 N THR B 141 O HIS B 133 SHEET 3 I 3 VAL B 145 PRO B 146 -1 O VAL B 145 N TYR B 142 SHEET 1 J 2 GLU B 148 VAL B 149 0 SHEET 2 J 2 GLY B 153 VAL B 154 -1 O GLY B 153 N VAL B 149 CRYST1 134.010 38.340 80.990 90.00 112.90 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007462 0.000000 0.003152 0.00000 SCALE2 0.000000 0.026082 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013404 0.00000